12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Monday's intraday session, several healthcare stocks experienced significant movements. TransCode Therapeutics (RNAZ), Vaccitech (VACC), Biophytis (BPTS), Avalo Therapeutics (AVTX), Cano Health (CANO), and Bluejay Diagnostics (BJDX) saw gains, while Brainstorm Cell (BCLI), Morphic Holding (MORF), SCYNEXIS (SCYX), Axcella Health (AXLA), MSP Recovery (LIFW), and T2 Biosystems (TTOO) experienced losses.
September 25, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Brainstorm Cell shares decreased by 38.7% to $0.5 during Monday's session, with a trading volume of 2.2 million shares. The market value of their outstanding shares is at $22.5 million.
The significant decrease in Brainstorm Cell's share price and the high trading volume indicates a negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Morphic Holding shares decreased by 32.67% to $24.7 during Monday's session, with a trading volume of 4.7 million shares. The company's market cap stands at $1.1 billion.
The significant decrease in Morphic Holding's share price and the high trading volume indicates a negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares rose 219.3% to $2.12 during Monday's session, with a trading volume of 72.3 million shares. The market value of their outstanding shares is at $4.2 million.
The significant increase in TransCode Therapeutics' share price and trading volume indicates a positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vaccitech shares increased by 82.73% to $3.07 during Monday's session, with a trading volume of 18.2 million shares. The market value of their outstanding shares is at $118.2 million.
The significant increase in Vaccitech's share price and trading volume indicates a positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100